Correction: Complement inhibitor CSMD1 acts as tumor suppressor in human breast cancer

Affiliations

• ¹ Department of Translational Medicine, Lund University, Malmö, Sweden.
• ² Department of Laboratory Medicine, Lund University, Lund, Sweden.
• ³ Department of Medical Biotechnology, Medical University of Gdańsk, Gdańsk, Poland.
• ⁴ Cardiff China Medical Research Collaborative, Cardiff University School of Medicine, Cardiff University, Cardiff, UK.
• ⁵ Department of Clinical Sciences, Lund University, Lund, Sweden.
• ⁶ Department of Pathology and Oncology, Juntendo University School of Medicine, Tokyo, Japan.